Two papers yanked for lack of formal ethics approval

By Nick Youngson

Get it in writing. That’s the moral in a pair of retractions in different journals after authors claimed to have received oral — but not written — ethics approval for their research.

One paper, in the International Journal of Pediatrics, a Hindawi title, came from a group in Kuwait and Greece. Titled “Prevalence and associated factors of peer victimization (bullying) among grades 7 and 8 middle school students in Kuwait, the article appeared in February 2017.

According to the retraction notice: Continue reading Two papers yanked for lack of formal ethics approval

Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Title: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction

What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported animal experiments. In addition, the corresponding author had no idea the paper had been submitted and published. How could a corresponding author be kept in the dark? It turns out, the journal was given an incorrect email address for him, so he didn’t receive any communications around the paper. (One author apparently used a third party editing company.) Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Second paper tied to drug scandal in Norway ski team retracted

Researchers in Norway have retracted a second high-profile exercise paper — again after running afoul of an ethical approval committee.

As part of the 2016 study, the researchers gave athletes asthma medication to measure its effect on signals from the nervous system to the lungs; although the drug appeared to have no detectable effect on the nervous system signals, 45 minutes after getting the drug, athletes (including those without asthma) showed an average slight increase in one measure of lung function.

Annette Birkeland, of The Norwegian National Research Ethics Committees (FEK), told us:

Continue reading Second paper tied to drug scandal in Norway ski team retracted

Journal bans author for three years after retracting paper with “serious ethical” problems

An anatomy journal has banned a researcher from submitting papers for three years after determining one of his recently published papers suffered from “serious ethical” issues.

According to Jae Seung Kang, associate editor at the journal Anatomy and Cell Biology (ACB), the paper’s sole authorJae Chul Lee—falsified both his affiliation and approval for conducting animal experiments in the paper, published online in March.

Kang said the journal discovered the issues after Lee submitted other papers to the journal this past August. During the journal’s review process, it discovered “over 70% redundancy”—ie, plagiarism—between the newly submitted papers and two now-retracted papers—the ACB paper as well as a 2015 paper published in the Journal of Pathology and Translational Medicine, on which Jae Chul Lee was corresponding author. The issues prompted the journal to conduct “an in-depth investigation,” Kang said. Continue reading Journal bans author for three years after retracting paper with “serious ethical” problems

Caught Our Notice: Ethics, data concerns prompt another retraction for convicted researchers

Via Wikimedia

Title: Unravelling the influence of mild traumatic brain injury (MTBI) on cognitive-linguistic processing: A comparative group analysis

What Caught our Attention: RW readers might already be familiar with Caroline Barwood and Bruce Murdoch, two researchers from Australia who had the rare distinction of being criminally charged for research misconduct. Both Barwood and Murdoch received suspended sentences after being found guilty of multiple counts of fraud. In September 2014, University of Queensland announced that: Continue reading Caught Our Notice: Ethics, data concerns prompt another retraction for convicted researchers

A paper about eye damage in astronauts got pulled for “security concerns.” Huh?

Here’s a head-scratcher: A 2017 paper examining why long space flights can cause eye damage has been taken down, with a brief note saying NASA, which sponsored the research, asked for the retraction because of “security concerns.”

According to the first author, the paper included information that could identify some of the astronauts that took part in the study — namely, their flight information. Although the author said he removed the identifying information after the paper was online, NASA still opted to retract it. But a spokesperson at NASA told us the agency did not supply the language for the retraction notice. The journal editor confirmed the paper was retracted for “research subject confidentiality issues,” but referred a question about who supplied the language of the notice back to NASA.

Now lawyers are involved.

So we still have some questions about this one. Here’s what we do know.

Continue reading A paper about eye damage in astronauts got pulled for “security concerns.” Huh?

Case report of stem cell therapy in child didn’t meet “ethical standards,” says journal

A journal has retracted a recent case report about a stem cell therapy in a child with cerebral palsy, after discovering the study failed to meet “ethical standards.”

According to the journal, Regenerative Medicine, the ethical issue is that the authors failed to report the case to the Ministry of Health, Labor and Welfare of Japan, which violates the country’s guidelines for conducting stem cell research. Unfortunately, we don’t know much more than that about what happened.

Laura Dormer, editorial director of Future Science Group, which publishes Regenerative Medicine, explained that the paper’s first author, Masato Kantake, requested the retraction because: Continue reading Case report of stem cell therapy in child didn’t meet “ethical standards,” says journal

Fertility docs said their study didn’t need ethics review. An investigation said they were wrong.

Arcispedale Santa Maria Nuova-IRCCS. Credit: IRCCS-ASMN

A journal is retracting a paper on the relative merits of one fertility procedure compared to another because the study never received ethical review or approval.

In the paper, “Intracytoplasmic morphologically selected sperm injection versus conventional intracytoplasmic sperm injection: a randomized controlled trial,” originally published Aug. 27, 2015 in Reproductive Biology and Endocrinology, the authors wrote: Continue reading Fertility docs said their study didn’t need ethics review. An investigation said they were wrong.

Uni dings schizophrenia studies for problems with informed consent, other flaws

Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.

The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.

According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.

A spokesperson for Human Psychopharmacology told us: Continue reading Uni dings schizophrenia studies for problems with informed consent, other flaws

Researcher who tangled with CrossFit loses two more papers

An exercise scientist who ran a study of the CrossFit exercise program without an approved human subjects protocol has lost two more papers to retraction.

Both papers were retracted on June 26 by the editors of the International Journal of Exercise Science (IJES) with the agreement of last author Steven Devor, a former professor at The Ohio State University. Both have been retracted because the studies were carried out without proper IRB approval.

Earlier in June, another paper from the CrossFit study — which is still at the center of a legal battle between CrossFit and a competitor in the market for exercise instructor licensing — was retracted by the Journal of Strength and Conditioning Research (JSCR) for improper IRB approval. Devor resigned from OSU the day after the first retraction.

Only one of the newly retracted papers had anything to do with the CrossFit study: Published in April 2014, this paper suggested that the so-called “paleo” diet — a diet focused on meat and vegetables — is associated with “unfavorable” changes in cholesterols and other blood-based cardiovascular biomarkers. In addition to following the diet, subjects also participated in a CrossFit exercise program. Continue reading Researcher who tangled with CrossFit loses two more papers